ArticleOncotarget2018

Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker.

Rachel A Levin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.